{"doi":"10.3390/epigenomes3020011","title":"Disruption of Broad Epigenetic Domains in PDAC Cells by HAT Inhibitors","abstract":"<jats:p>The spreading of epigenetic domains has emerged as a distinguishing epigenomic phenotype for diverse cell types. In particular, clusters of H3K27ac- and H3K4me3-marked elements, referred to as super-enhancers, and broad H3K4me3 domains, respectively, have been linked to cell identity and disease states. Here, we characterized the broad domains from different pancreatic ductal adenocarcinoma (PDAC) cell lines that represent distinct histological grades. Our integrative genomic analysis found that human derived cell line models for distinct PDAC grades exhibit characteristic broad epigenetic features associated with gene expression patterns that are predictive of patient prognosis and provide insight into pancreatic cancer cell identity. In particular, we find that genes marked by overlapping Low-Grade broad domains correspond to an epithelial phenotype and hold potential as markers for patient stratification. We further utilize ChIP-seq to compare the effects of histone acetyltransferase (HAT) inhibitors to detect global changes in histone acetylation and methylation levels. We found that HAT inhibitors impact certain broad domains of pancreatic cancer cells. Overall, our results reveal potential roles for broad domains in cells from distinct PDAC grades and demonstrate the plasticity of particular broad epigenomic domains to epigenetic inhibitors.</jats:p>","journal":"Epigenomes","year":2019,"id":32638,"datarank":0.4493598410330987,"base_score":2.995732273553991,"endowment":2.995732273553991,"self_citation_contribution":0.4493598410330987,"citation_network_contribution":0.0,"self_endowment_contribution":0.4493598410330987,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":19,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":172381,"name":"Joseph R. Boyd","orcid":"0000-0002-8969-9676","position":1,"is_corresponding":false},{"id":49920,"name":"Gary S. Stein","orcid":"0000-0001-8762-5422","position":2,"is_corresponding":false},{"id":88614,"name":"Victor X. Jin","orcid":"0000-0002-8765-3471","position":3,"is_corresponding":false},{"id":75998,"name":"Seth Frietze","orcid":"0000-0003-4058-3661","position":4,"is_corresponding":false},{"id":172380,"name":"Diana L. Gerrard","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"31815011","pmcid":"PMC6897394","openalex_id":"https://openalex.org/W31815011","authors":[],"funders":[{"funder_name":"NCI NIH HHS","grant_id":"U54 CA217297","title":null},{"funder_name":"NIGMS NIH HHS","grant_id":"U54 GM115516","title":null},{"funder_name":"NIGMS NIH HHS","grant_id":"R01 GM114142","title":null},{"funder_name":"NCI NIH HHS","grant_id":"P01 CA082834","title":null},{"funder_name":"NCI NIH HHS","grant_id":"R01 CA230618","title":null},{"funder_name":"NIGMS NIH HHS","grant_id":"R01 GM129338","title":null},{"funder_name":"National Institutes of Health","grant_id":"1R01CA230618-01","title":"Understanding Ikaros molecular functions for targeted therapies of pre-B ALL"},{"funder_name":"National Institutes of Health","grant_id":"5P01CA082834-14","title":"ADMINISTRATIVE"},{"funder_name":"National Institutes of Health","grant_id":"5R01GM114142-04","title":"Omics analysis of three-dimensional transcriptional regulation"},{"funder_name":"National Institutes of Health","grant_id":"1R01GM129338-01","title":"Deciphering the molecular mechanisms of histone code recognition by ATAD2/B"},{"funder_name":"National Institutes of Health","grant_id":"5R01GM114142-09","title":"Omics analysis of three-dimensional transcriptional regulation"},{"funder_name":"National Institutes of Health","grant_id":"5U54CA217297-02","title":"Systems Analysis of Epigenomic Architecture in Cancer Progression"},{"funder_name":"National Institutes of Health","grant_id":"5R01CA230618-05","title":"Understanding Ikaros molecular functions for targeted therapies of pre-B ALL"}],"total_grants":13,"fwci":0.0,"citation_percentile":0.00428057,"influential_citations":1,"citation_trend":[],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"http://ci.nii.ac.jp/naid/110004706132","host_type":"journal"},{"url":"https://www.mdpi.com/2075-4655/3/2/11/pdf?version=1561443409","host_type":"GOLD"},{"url":"https://www.mdpi.com/2075-4655/3/2/11/pdf?version=1561443409","host_type":"publisher"},{"url":"https://www.mdpi.com/2075-4655/3/2/11/pdf","host_type":"publisher"},{"url":"https://seirei-univ.repo.nii.ac.jp/?action=repository_action_common_download&item_id=623&item_no=1&attribute_id=18&file_no=1","host_type":"repository"},{"url":"http://dx.doi.org/10.3390/epigenomes3020011","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6897394","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC6897394","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC6897394?pdf=render","host_type":"Europe_PMC"},{"url":"https://doi.org/10.3390/epigenomes3020011","host_type":""},{"url":"https://pubmed.ncbi.nlm.nih.gov/31815011","host_type":""},{"url":"https://doaj.org/article/0ea3879ba5e94c27b338ba3e3a2322b2","host_type":""},{"url":"https://dx.doi.org/10.3390/epigenomes3020011","host_type":""}],"fields_of_study":["Histone Deacetylase Inhibitors Research","Biology","Medicine","0301 basic medicine","03 medical and health sciences"],"mesh_terms":[],"keywords":["Computer science","Pancreatic cancer","epigenomics","Super-enhancers","Genetics","QH426-470","TP248.13-248.65","Article","Biotechnology"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[{"name":"geo"},{"name":"nct"}],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-09T13:49:43.514912Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}